Migraine Clinical Trial
Official title:
The Effects of Cervical Stabilization Exercise Training With Telerehabilitation in Individuals With Migraine
The aim of our study is to investigate the effects of cervical stabilization exercise training applied with telerehabilitation in individuals with migraine.
Status | Not yet recruiting |
Enrollment | 40 |
Est. completion date | June 2023 |
Est. primary completion date | February 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 55 Years |
Eligibility | Inclusion Criteria: - Being between the ages of 18-55, - To be diagnosed with migraine by a neurologist according to International Headache Society criteria, - Having at least 3 migraine attacks per month, - Volunteering to participate in the study, - Having the opportunity to access devices such as computers, phones and tablets with internet connection, - Not having any problems that prevent cooperation and understanding Exclusion Criteria: - Having other accompanying headache types, - Being pregnant, - Being in the breastfeeding period, - Having a history of trauma, fracture or surgery in the craniocervical region, - Presence of concomitant neurological and/or inflammatory rheumatic disease - Presence of serious psychiatric problems, - History of malignancy, - Changes in medical treatment during the study period, - Receiving physiotherapy for the cervical region in the last 6 months |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Ankara Yildirim Beyazit University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The characteristic of the migraine | The characteristic of the migraine will be evaluated with the "Headache Diary". | change from baseline at 8 weeks | |
Secondary | Cervical range of motion | Cervical range of motion was evaluated using the goniometer | change from baseline at 8 weeks | |
Secondary | Upper cervical region movements | Upper cervical region movements will be evaluated with a Cervical Range of Motion device | change from baseline at 8 weeks | |
Secondary | Performance of the deep neck flexor muscles | Performance of the deep neck flexor muscles will be evaluated with a Stabilizer Pressure Biofeedback Unit | change from baseline at 8 weeks | |
Secondary | Cranio-vertebral angle | The cranio-vertebral angle will be measured with a goniometer | change from baseline at 8 weeks | |
Secondary | Disability Status | The Turkish version of Migraine Disability Assessment Scale will be used to determine the disability status in daily activities of individuals due to migraine | change from baseline at 8 weeks | |
Secondary | Sleep quality | Sleep quality will be evaluated with the Turkish version of Jenkins Sleep Scale | change from baseline at 8 weeks | |
Secondary | Life quality | Life quality will be evaluated with the Turkish version of Headache Impact Test | change from baseline at 8 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05525611 -
Cabergoline as a Preventive Treatment for Chronic Migraine
|
N/A | |
Completed |
NCT06192173 -
Patent Foramen Ovale Closure in Migraine
|
||
Recruiting |
NCT03832998 -
Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine
|
Phase 3 | |
Enrolling by invitation |
NCT04196933 -
Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma
|
N/A | |
Not yet recruiting |
NCT06428838 -
Eptinezumab as an Adjunct to Standard of Care for Migraine in an Acute Emergency Context
|
Phase 3 | |
Completed |
NCT06304675 -
Manageable Environmental Factors in Migraine
|
||
Completed |
NCT04084314 -
Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study
|
Phase 4 | |
Recruiting |
NCT05517200 -
Pilot Study for a Machine Learning Test for Migraine
|
||
Completed |
NCT04179474 -
Safety, Tolerability and Drug- Drug Interaction Study of Ubrogepant With Erenumab or Galcanezumab in Participants With Migraine
|
Phase 1 | |
Recruiting |
NCT04603976 -
Registry for Migraine - Clinical Core
|
Phase 4 | |
Completed |
NCT03597529 -
CHOCOlate MeLatonin for AdolescenT MigrainE
|
Phase 2 | |
Completed |
NCT04197349 -
Safety, Tolerability and Pharmacokinetics of ALD1910 in Healthy Men and Woman
|
Phase 1 | |
Recruiting |
NCT05891808 -
miR-155 Expression in Episodic and Chronic Migraine
|
||
Active, not recruiting |
NCT05064371 -
Long-Term Extension Study With Eptinezumab as Preventive Treatment in Participants With Migraine in Japan
|
Phase 3 | |
Suspended |
NCT04069572 -
Vibratory Stimulation for the Treatment of Chronic Pain
|
N/A | |
Not yet recruiting |
NCT04859374 -
Chronic Pain and Conditioned Pain Modulation After on Line-behavioral Approach
|
N/A | |
Not yet recruiting |
NCT03083860 -
Evaluation of Migraine Management Mobile App Combined With Electrophysiological Measurements for Identification of Migraine Attack Risk and Beneficial Preventive Actions.
|
N/A | |
Completed |
NCT02905227 -
A Study of the Pulmonary Safety and Pharmacokinetics of Zolmitriptan Inhalation Powder
|
Phase 1 | |
Enrolling by invitation |
NCT02532023 -
The Combined Effects of omega3 Fatty Acids and Curcumin Supplementation on Inflammatory and Endothelial Factors in Migraine Patients
|
Phase 4 | |
Completed |
NCT02108678 -
One-Day Intervention for Depression and Impairment in Migraine Patients
|
N/A |